City of Industry, CA–AIDP announced that a double-blind, placebo-controlled study study, titled A Magtein®, Magnesium L-Threonate, Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults, has been published in the journal Nutrients.
Study shows memory benefits
Magtein®PS, a magnesium L-threonate (Magtein)- and phosphatidylserine-based formulation that also contains vitamins C and D, was tested for its cognitive benefits in 109 healthy Chinese adults aged 18–65. Subjects were randomly assigned to receive either Magtein®PS or placebo capsules, at a dose of 2 g/day. A clinical memory test was administered before and 30 days after subjects received the supplement. The findings: Subjects in the Magtein group showed significant improvements over the control group in all five subcategories the test, as well as on overall memory quotient scores.
“This study is the third human clinical publication in healthy adults and validates Magtein’s cognitive support for a broad age group as well as an ethic group,” said Dr. Jennifer Gu, Vice President of Research and Development at AIDP, in a press release. “There is a significant research pipeline for Magtein, and we are pleased with this recent publication.”
Magtein benefits for mood, stress & more
Magtein is a patented magnesium l-threonate that is available exclusively from AIDP. It was introduced in 2014 after scientists from the Massachusetts Institute of Technology (MIT) determined it can effectively deliver magnesium to brain cells (as noted in the 2010 publication in the journal Neuron). Magtein provides noticeable consumer benefits for cognition, AIDP reports, and neurological health including support for mood, sleep, stress and anxiety.